We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study Reveals Limits of Pregnancy Testing

By HospiMedica staff writers
Posted on 15 Oct 2001
A study has demonstrated that around 10% of clinical pregnancies are undetectable on the first day of missed menses by an extremely sensitive assay for human chorionic gonadotropin (hCG). More...
The researchers say this suggests that perhaps an even larger percentage of pregnancies are undetected by home test kits because of practical limitations and user error. The study was published in the October 10, 2001, issue of The Journal of the American Medical Association (JAMA).

Pregnancy cannot be detected before implantation. The study, which involved 221 women, found that pregnancy tests may not be accurate on the first day or so after a missed period because implantation had not yet occurred. Attachment occurs roughly nine days after fertilization but can range from six to 12 days because of the natural variability in ovulation. The researchers found that 10% of the embryo attachments—and hence new pregnancies—had not occurred by the day the women expected their periods to begin.

"These findings mean that if women were to buy a test kit, follow the directions, and test themselves on the first day of their expected periods, the test would be negative for many women, and they would not know that they'd become pregnant,” said Dr. Allen J. Wilcox, faculty member at the University of North Carolina at Chapel Hill (USA; www.unc.edu) and senior investigator of the study. "This is true even if their doctors had given them a blood test for pregnancy that day.”





Related Links:
JAMA

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.